Skip to content
★ Sign in to follow
DS

Dennis Slamon

Board Director
Director
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€448k

Latest filing published 20 Mar 2024 for Biomarin Pharmaceutical INC, €732k.

Filing timeline

BuySale
Dennis Slamon

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Dennis Slamon: trading record in brief

This profile gathers the share dealings of Dennis Slamon in Biomarin Pharmaceutical Inc, where the filings describe the role as board member. Between 19 March 2014 and 18 March 2024, the trades on record add up to 19 filings.

Sales make up the whole of the open-market record (6 sales, €448k). Other entries cover 12 share grants and 1 option exercise.

The latest filing, published on 20 March 2024, reports an option exercise of €732k in Biomarin Pharmaceutical Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Dennis Slamon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations